ARCHIVES

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

This article is from The Cancer Letter archive.

Vol. 38 No. 14 | April 6, 2012

Download PDF Visit The Full Archive

Related Articles

FDA Approves Bexxar For Non-Hodgkin’s Lymphoma

June 27, 2003

NIH Advisors Urge Overhaul Of Peer Review System.

March 7, 2008

Research community needs to be prepared for budget “flattening,” NCI director says.

March 25, 2005

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998

Colorado Governor Signs Bill Mandating Reimbursement For Mammography Screening

April 21, 1989

Panel Urges New Research Consortium For Stomach, Esophageal Cancers

January 17, 2003